Jan Vanwelkenhuyzen
- ORCID iD
-
0000-0001-6180-1889
Show
Sort by
-
Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial
-
Development of an androgen receptor (AR) splice variant targeting, cell-free RNA and treatment-predictive biomarker assay for men with metastatic castration-resistant prostate cancer (mCRPC)
-
Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review
-
- Conference Paper
- C3
- open access
Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach
-
Inferring the genomic landscape of lymph-node positive high-risk prostate cancer
-
Tracking the origins of metastatic seeding in de novo metastatic prostate cancer